Reliability of Visual Analog Scale and Numeric Rating Scale for the Assessment of Disease Activity in Systemic Lupus Erythematosus.
Journal
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
ISSN: 1536-7355
Titre abrégé: J Clin Rheumatol
Pays: United States
ID NLM: 9518034
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
pubmed:
4
1
2020
medline:
24
6
2021
entrez:
4
1
2020
Statut:
ppublish
Résumé
To determine the reliability of SLE patients' disease activity measurements. This was a cross-sectional study conducted (August 2016-December 2017) at 2 main public Peruvian hospitals, 1 with a comprehensive lupus care program. Patients assessed their disease activity with a visual analog scale (VAS) (0-100 mm) or a numerical rating scale (NRS) (0-4) before and after their physician's (MD's) assessment. Demographic and disease-related characteristics were recorded. Reliability of patients' disease activity before and after MD's assessment was determined using Spearman rank correlation. Factors possibly associated with this variability were examined with Spearman rank correlation and Mann-Whitney U test. Two hundred forty, mostly Mestizo, SLE patients were included; mean (SD) age and disease duration (diagnosis) were 34.9 (12.9) years and 10.1 (7.0) years, respectively. The Mexican version of the Systemic Lupus Erythematosus Disease Activity Index was 1.9 (2.7), and the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index was 1.2 (1.5). The correlations between NRS and VAS before and after the MD's assessment were ρ = 0.839; p < 0.001; and ρ = 0.872; p < 0.001, respectively. Visual analog scale and NRS were higher before than after the MD's assessment (VAS 29.3 [26.5] and 26.5 [24.9], p = 0.052; and NRS (1.5 [1.2] and 1.3 [1.1], p = 0.003); only the comprehensive program explained this variability (p = 0.043). The reliability of VAS and NRS was ρ = 0.917 and ρ = 0.861, p < 0.001, before and after for the comprehensive program and ρ = 0.710 and ρ = 0.785, p < 0.001, for before and after for the regular program. Both VAS an NRS are highly reliable. Patients scored higher before than after their physicians' assessment but that these differences were smaller for the patients in the comprehensive care program than in the regular one.
Identifiants
pubmed: 31899713
doi: 10.1097/RHU.0000000000001274
pii: 00124743-202010002-00014
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
S170-S173Références
Feld J, Isenberg D. Why and how should we measure disease activity and damage in lupus?Presse Med. 2014;43(6 pt 2):e151–e156.
Mosca M, Bombardieri S. Assessing remission in systemic lupus erythematosus. Clin Exp Rheumatol. 2006;24(6 suppl 43):S-99–S-104.
Abaza NM, El-Mallah RM, Shaaban A, et al. Vitamin D deficiency in Egyptian systemic lupus erythematosus patients: how prevalent and does it impact disease activity?Integr Med Insights. 2016;11:27–33.
Raymond WD, Eilertsen GO, Shanmugakumar S, et al. The impact of cytokines on the health-related quality of life in patients with systemic lupus erythematosus. J Clin Med. 2019;8. pii: E857.
pii: e857
Nowicka-Sauer K, Hajduk A, Kujawska-Danecka H, et al. Illness perception is significantly determined by depression and anxiety in systemic lupus erythematosus. Lupus. 2018;27:454–460.
Jones JT, Cunningham N, Kashikar-Zuck S, et al. Pain, fatigue, and psychological impact on health-related quality of life in childhood-onset lupus. Arthritis Care Res. 2016;68:73–80.
Sheikh SZ, Kaufman K, Gordon BB, et al. Evaluation of the self-directed format of walk with ease in patients with systemic lupus erythematosus: the Walk-SLE Pilot Study. Lupus. 2019;28:764–770.
Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.
Mok CC, Chan KL, Ho LY. Association of depressive/anxiety symptoms with quality of life and work ability in patients with systemic lupus erythematosus. Clin Exp Rheumatol. 2016;34:389–395.
Schmeding A, Schneider M. Fatigue, health-related quality of life and other patient-reported outcomes in systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2013;27:363–375.
Aparicio-Soto M, Sanchez-Hidalgo M, Alarcon-de-la-Lastra C. An update on diet and nutritional factors in systemic lupus erythematosus management. Nutr Res Rev. 2017;30:118–137.
O'Dwyer T, Durcan L, Wilson F. Exercise and physical activity in systemic lupus erythematosus: a systematic review with meta-analyses. Semin Arthritis Rheum. 2017;47:204–215.
Lundeberg T, Lund I, Dahlin L, et al. Reliability and responsiveness of three different pain assessments. J Rehab Med. 2001;33:279–283.
Peters ML, Patijn J, Lame I. Pain assessment in younger and older pain patients: psychometric properties and patient preference of five commonly used measures of pain intensity. Pain Med. 2007;8:601–610.
Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore. 1994;23:129–138.
Daut RL, Cleeland CS. The prevalence and severity of pain in cancer. Cancer. 1982;50:1913–1918.
Sarzi-Puttini P, Fiorini T, Panni B, et al. Correlation of the score for subjective pain with physical disability, clinical and radiographic scores in recent onset rheumatoid arthritis. BMC Musculoskelet Disord. 2002;3:18.
Gallagher EJ, Liebman M, Bijur PE. Prospective validation of clinically important changes in pain severity measured on a visual analog scale. Ann Emerg Med. 2001;38:633–638.
Kelly AM. Does the clinically significant difference in visual analog scale pain scores vary with gender, age, or cause of pain?Acad Emerg. 1998;5:1086–1090.
Arora S, Nika A, Trupin L, et al. Does systemic lupus erythematosus care provided in a lupus clinic result in higher quality of care than that provided in a general rheumatology clinic?Arthritis Care Res (Hoboken). 2018;70:1771–1777.
FitzGerald JD, Grossman JM. Validity and reliability of retrospective assessment of disease activity and flare in observational cohorts of lupus patients. Lupus. 1999;8:638–644.
Hjermstad MJ, Fayers PM, Haugen DF, et al. Studies comparing numerical rating scales, verbal rating scales, and visual analogue scales for assessment of pain intensity in adults: a systematic literature review. J Pain Symptom Manag. 2011;41:1073–1093.
Khadka J, Gothwal VK, McAlinden C, et al. The importance of rating scales in measuring patient-reported outcomes. Health Qual Life Outcomes. 2012;10:80.
Garratt AM, Helgeland J, Gulbrandsen P. Five-point scales outperform 10-point scales in a randomized comparison of item scaling for the patient experiences questionnaire. J Clin Epidemiol. 2011;64:200–207.
Hawthorne G, Mouthaan J, Forbes D, et al. Response categories and anger measurement: do fewer categories result in poorer measurement?: Development of the DAR5. Soc Psychiatry Psychiatr Epidemiol. 2006;41:164–172.
Askanase AD, Daly RP, Okado M, et al. Development and content validity of the Lupus Foundation of America Rapid Evaluation of Activity in Lupus (LFA-REAL): a patient-reported outcome measure for lupus disease activity. Health Qual Life Outcomes. 2019;17:99.
Leong KP, Chong EY, Kong KO, et al. Discordant assessment of lupus activity between patients and their physicians: the Singapore experience. Lupus. 2010;19:100–106.